We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/7/2021 14:32 | Perhaps 1440? | netcurtains | |
30/7/2021 12:54 | 1430 a possibility if wind in right direction | netcurtains | |
30/7/2021 11:18 | High risk for any bears with possible breakup/sale of parts etc. Not IMO a good target. | alphorn | |
30/7/2021 11:07 | Hedgehogs will never let GSK rise as long as they can put a negative spin on the share price by shorting it on every rise in the share price no matter how big or small,Glaxo as compared to other pharmas has a very low basic share price for the live dealing in the markets. | abdullla | |
30/7/2021 10:23 | We are edging up. It finished in the US last night at the equivalent of about 1422 | netcurtains | |
30/7/2021 10:14 | When will the price respond to good product success: GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps | tradermichael | |
30/7/2021 09:43 | So can we break 1430 today? Come on thats not too much to ask. we're a 1/3 of the way there and its only 9:45 | netcurtains | |
30/7/2021 08:53 | We're getting are higher lows so lets get some higher highs now. | netcurtains | |
29/7/2021 20:56 | US GSK up significantly higher than UK rise so bodes well for UK tomorrow. Touchwood. | netcurtains | |
29/7/2021 19:14 | Market up GSK manages 5p. This will never be above 15 quid with current management | spoole5 | |
29/7/2021 16:39 | What a closing price down from 20p to 4p,market is a sham. | abdullla | |
29/7/2021 16:37 | still going up, so that is the main thing. Market likes the figures. | netcurtains | |
29/7/2021 16:03 | Flatters, only to then deceive. | daveboy19 | |
29/7/2021 15:36 | While back at the ranch the share price is going back to where it resides | abdullla | |
29/7/2021 14:50 | It appears to be rising nicely in New York Over the magic 40 barrier. | netcurtains | |
29/7/2021 14:21 | not a chance of 1430 today | eurofox | |
29/7/2021 13:31 | Yes higher lows. Be nice to break 1430 today. Lets see how it ends up after New York opens. Yesterday GSK was flat in USA so it should bounce up today (one assumes). | netcurtains | |
29/7/2021 12:52 | Moving day average up. Buy signal on my TA. GLA | charlie9038 | |
29/7/2021 12:33 | The pigs working in hedgehogs will always control the share price of GSK which will stay between 13-14 pounds,it is a good shorting pick amongst other stocks . | abdullla | |
29/7/2021 10:52 | Come on GSK lets get this over 1500. This price is absurdly cheap for such great results and potential for a great future. And dividends. | netcurtains | |
29/7/2021 10:46 | No, GSK bottled it, literally. Anyway, final comment on this. | alex1621 | |
29/7/2021 10:24 | Anyway there is no recovery until it at the very least breaks 1500 | netcurtains | |
29/7/2021 10:23 | I thought they bottled it? The process is Oxford's surely? | netcurtains | |
29/7/2021 10:05 | They controlled the process, and put their name to it. | alex1621 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions